Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Multistate Investigation Announced into Premera Cyberattack

By Drug Discovery Trends Editor | March 26, 2015

Washington state’s insurance commissioner announced Tuesday a multistate investigation into this winter’s cyberattack on Premera Blue Cross.

Insurance Commissioner Mike Kreidler said he plans to work with his counterparts in Alaska and Oregon to look into operations at Premera, which is based in Mountlake Terrace, Washington. The investigation will explore the cyberattack disclosed by Premera last week, in which hackers accessed the personal information of 11 million consumers, including 6 million in Washington, between last May and the exploit’s Jan. 29 discovery.

“I remain seriously concerned at the amount of time it took Premera to notify its policyholders of the breach,” Kreidler said in a statement announcing the investigation. “When you buy and use your insurance, you share your personal information with the company and you expect it to be protected during those transactions.”

The scope of the investigation may also include the extent of the financial damage done, steps taken to prevent a future attack and other cybersecurity aspects of the attack, Kreidler said. No timeline was given for the investigation, which will involve on-site reviews of Premera’s books and activities. Additional states could join the investigation team as it explores how far the security breach affected other members of the “Blue Card” system, which is Premera’s national provider network.

Oregon insurance officials said Tuesday the breach exposed personal identification from 250,000 people who belong to the Lifewise Insurance Plan of Oregon, a Premera subsidiary.

“Oregon takes the protection of personal identifying information very seriously, and this investigation will closely scrutinize the data security practices of Lifewise,” Oregon Insurance Commissioner Laura Cali said in a statement.

After the March 17 announcement of the cyberattack, Premera said it would provide two years of credit monitoring and identity theft protection services to anyone affected. The FBI is investigating the attack, and Premera has also hired the security firm Mandiant to investigate what happened and help repair its systems.

In Alaska, where an estimated 700,000 insurance consumers were affected, including 80,000 current and former state employees, Gov. Bill Walker last week encouraged enrollment in the protection services Premera offered to victims.

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE